stroke

EM Cases: ED Stroke Management in the Age of Endovascular Therapy

Which patients need what type of scanning? Where should that scanning be done – at the stroke center or at the peripheral center? Which patients should get systemic thrombolytics? Which patients should get endovascular therapy? In this EM Cases main episode podcast, a follow up to our episode on TIA released in November 2018 with Walter Himmel and David Dushenski, we try to simplify the confusing time-based and brain tissue-based options for stroke management…

EM Cases: ED Stroke Management in the Age of Endovascular Therapy Read More »

EM@3AM: Spontaneous Intracerebral Hemorrhage

A 65-year-old male presents with altered mental status and right sided weakness. Symptoms began approximately two hours earlier when the patient began to complain of a severe headache. He has become more confused and is now unable to walk normally. Vital Signs: BP 202/98, HR 89, RR 12, T 36.7, SpO2 98% RA. Exam reveals an uncomfortable gentleman who is able to state his name, but unable to give the correct date or his location. He has profound right sided weakness in both upper and lower extremities. What’s your next step?

EM@3AM: Spontaneous Intracerebral Hemorrhage Read More »

Endovascular Stroke Therapy: Is This the New Standard?

Every few years, we come to a crossroads that makes us reexamine our current clinical practice and consider a better intervention. For the past twenty years, patients presenting with acute ischemic stroke have had essentially one option for therapy: intravenous thrombolytics. Since the NINDS-2 trial in 1995 [1], tPA has erupted onto the scene of stroke management and has become the gold standard despite ongoing questions behind the true efficacy of tPA.

Endovascular Stroke Therapy: Is This the New Standard? Read More »

I highly recommend steve. Com miss cool cool. The two therapeutic essential oils which we found to be most effective at quickly destroying fungal infections is.